150 related articles for article (PubMed ID: 2411645)
21. Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers.
Ehrlich BE; Schen CR; Garcia ML; Kaczorowski GJ
Proc Natl Acad Sci U S A; 1986 Jan; 83(1):193-7. PubMed ID: 2417238
[TBL] [Abstract][Full Text] [Related]
22. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
[TBL] [Abstract][Full Text] [Related]
23. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
[TBL] [Abstract][Full Text] [Related]
24. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
Janis RA; Rampe D; Sarmiento JG; Triggle DJ
Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
[TBL] [Abstract][Full Text] [Related]
25. Modulation of calcium channel function by drugs.
Schramm M; Towart R
Life Sci; 1985 Nov; 37(20):1843-60. PubMed ID: 2414632
[TBL] [Abstract][Full Text] [Related]
26. Calcium channel modulators and calcium channels.
Towart R; Schramm M
Biochem Soc Symp; 1985; 50():81-95. PubMed ID: 2428373
[TBL] [Abstract][Full Text] [Related]
27. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
Schramm M; Thomas G; Towart R; Franckowiak G
Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
[TBL] [Abstract][Full Text] [Related]
28. Ethanol-induced component of 45Ca2+ uptake in PC12 cells is sensitive to Ca2+ channel modulating drugs.
Greenberg DA; Carpenter CL; Messing RO
Brain Res; 1987 Apr; 410(1):143-6. PubMed ID: 2438011
[TBL] [Abstract][Full Text] [Related]
29. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.
Hess P; Lansman JB; Tsien RW
Nature; 1984 Oct 11-17; 311(5986):538-44. PubMed ID: 6207437
[TBL] [Abstract][Full Text] [Related]
30. Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.
Hattori Y; Hazama S; Kanno M; Nakao Y
Br J Pharmacol; 1986 Feb; 87(2):299-305. PubMed ID: 2420406
[TBL] [Abstract][Full Text] [Related]
31. Activators and inactivators of Ca++ channels: new perspectives.
Spedding M
J Pharmacol; 1985; 16(4):319-43. PubMed ID: 2419702
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
Bodewei R; Hering S; Schubert B; Wollenberger A
Biomed Biochim Acta; 1987; 46(8-9):S688-90. PubMed ID: 2449201
[TBL] [Abstract][Full Text] [Related]
33. Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells.
Uehara A; Hume JR
J Gen Physiol; 1985 May; 85(5):621-47. PubMed ID: 2582076
[TBL] [Abstract][Full Text] [Related]
34. Nifedipine and BAY K inhibit contraction independently from their action on calcium channels.
Jacquemond V; Rougier O
Biochem Biophys Res Commun; 1988 May; 152(3):1002-7. PubMed ID: 2454099
[TBL] [Abstract][Full Text] [Related]
35. L-type Ca(2+) currents overlapping threshold Na(+) currents: could they be responsible for the "slip-mode" phenomenon in cardiac myocytes?
Piacentino V; Gaughan JP; Houser SR
Circ Res; 2002 Mar; 90(4):435-42. PubMed ID: 11884373
[TBL] [Abstract][Full Text] [Related]
36. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
Nakaya H; Hattori Y; Tohse N; Kanno M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
[TBL] [Abstract][Full Text] [Related]
37. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
38. The action of diltiazem and gallopamil (D600) on calcium channel current and charge movement in mouse Purkinje neurons.
Bournaud R; Hidalgo J; Melliti K; Shimahara T
Neurosci Lett; 1998 Jan; 241(2-3):163-6. PubMed ID: 9507946
[TBL] [Abstract][Full Text] [Related]
39. Photoalteration of calcium channel blockade in the cardiac Purkinje fiber.
Sanguinetti MC; Kass RS
Biophys J; 1984 May; 45(5):873-80. PubMed ID: 6329345
[TBL] [Abstract][Full Text] [Related]
40. Slow channel calcium activators, a new group of pharmacological agents.
Preuss KC; Gross GJ; Brooks HL; Warltier DC
Life Sci; 1985 Oct; 37(14):1271-8. PubMed ID: 2413326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
